Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti‐infliximab formation

OBJECTIVES: Correlation of serum trough infliximab levels and antibodies to infliximab (anti‐infliximab) with clinical response in ankylosing spondylitis. METHODS: In accordance with the international ASsessment in Ankylosing Spondylitis (ASAS) consensus statement, patients were treated with inflixi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: de Vries, Mirjam K, Wolbink, Gerrit Jan, Stapel, Steven O, de Vrieze, Henk, van Denderen, J Christiaan, Dijkmans, Ben A C, Aarden, Lucien A, van der Horst‐Bruinsma, Irene E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2007
Gaiak:
Concise Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955152/
https://ncbi.nlm.nih.gov/pubmed/17472991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.072397
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak